U.S. Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Study Design, By Indication by Study Design, By Sponsor, By Service, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1
                        1.9.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Clinical Trials Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Regulatory Landscape
                    3.4. Technological Landscape
                    3.5. Pricing Model Analysis
                    3.6. Clinical Trial Volume Analysis, 2024
                    3.7. U.S. Clinical Trials Market Analysis Tools
                        3.7.1. Porter’s Five Forces Analysis
                        3.7.2. PESTEL Analysis
                        3.7.3. COVID-19 Impact Analysis
                    3.8. Product Pipeline Analysis by Stage
                        3.8.1. Therapeutics in Development
                        3.8.2. Vaccines in Development
Chapter 4. U.S. Clinical Trials Market: Phase Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Clinical Trials Market: Phase Movement Analysis & Market Share, 2024 & 2030
                    4.3. Phase I
                        4.3.1. Phase I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Phase II
                        4.4.1. Phase II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Phase III
                        4.5.1. Phase III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Phase IV
                        4.6.1. Phase IV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Clinical Trials Market: Study Design Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Clinical Trials Market: Study Design Movement Analysis & Market Share, 2024 & 2030
                    5.3. Interventional
                        5.3.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. Observational
                        5.4.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Expanded Access
                        5.5.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Clinical Trials Market: Indication Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Clinical Trials Market: Indication Movement Analysis & Market Share, 2024 & 2030
                    6.3. Autoimmune/Inflammation
                        6.3.1. Autoimmune/Inflammation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.2. Rheumatoid Arthritis
                            6.3.2.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.3. Multiple Sclerosis
                            6.3.3.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.4. Osteoarthritis
                            6.3.4.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.5. Irritable Bowel Syndrome (IBS)
                            6.3.5.1. Irritable Bowel Syndrome (IBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.6. Others
                            6.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. Pain Management
                        6.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.2. Chronic Pain
                            6.4.2.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.3. Acute Pain
                            6.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Oncology
                        6.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.5.2. Blood Cancer
                            6.5.2.1. Blood Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.5.3. Solid Tumors
                            6.5.3.1. Solid Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.5.4. Others
                            6.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. CNS Conditions
                        6.6.1. CNS Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.2. Epilepsy
                            6.6.2.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.3. Parkinson's Disease (PD)
                            6.6.3.1. Parkinson's Disease (PD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.4. Huntington's Disease
                            6.6.4.1. Huntington's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.5. Stroke
                            6.6.5.1. Stroke Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.6. Traumatic Brain Injury (TBI)
                            6.6.6.1. Traumatic Brain Injury (TBI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.7. Amyotrophic Lateral Sclerosis (ALS)
                            6.6.7.1. Amyotrophic Lateral Sclerosis (ALS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.8. Muscle Regeneration
                            6.6.8.1. Muscle Regeneration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.9. Others
                            6.6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Diabetes
                        6.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.8. Obesity
                        6.8.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.9. Cardiovascular
                        6.9.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.10. Others
                        6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Clinical Trials Market: Indication Movement Analysis & Market Share, 2024 & 2030
                    7.3. Autoimmune/Inflammation
                        7.3.1. Autoimmune/Inflammation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.2. Interventional
                            7.3.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.3. Observational
                            7.3.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.4. Expanded Access
                            7.3.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Pain Management
                        7.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.2. Interventional
                            7.4.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.3. Observational
                            7.4.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.4.4. Expanded Access
                            7.4.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Oncology
                        7.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.2. Interventional
                            7.5.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.3. Observational
                            7.5.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.5.4. Expanded Access
                            7.5.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. CNS Conditions
                        7.6.1. CNS Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.2. Interventional
                            7.6.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.3. Observational
                            7.6.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.6.4. Expanded Access
                            7.6.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.7. Diabetes
                        7.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.7.2. Interventional
                            7.7.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.7.3. Observational
                            7.7.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.7.4. Expanded Access
                            7.7.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.8. Obesity
                        7.8.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.8.2. Interventional
                            7.8.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.8.3. Observational
                            7.8.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.8.4. Expanded Access
                            7.8.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.9. Cardiovascular
                        7.9.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.9.2. Interventional
                            7.9.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.9.3. Observational
                            7.9.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.9.4. Expanded Access
                            7.9.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.10. Others
                        7.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.10.2. Interventional
                            7.10.2.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.10.3. Observational
                            7.10.3.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.10.4. Expanded Access
                            7.10.4.1. Expanded Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. Clinical Trials Market: Service Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. Clinical Trials Market: Sponsor Movement Analysis & Market Share, 2024 & 2030
                    8.3. Protocol Designing
                        8.3.1. Protocol Designing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.4. Site Identification
                        8.4.1. Site Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Patient Recruitment
                        8.5.1. Patient Recruitment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.6. Laboratory Services
                        8.6.1. Laboratory Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.7. Bioanalytical Testing Services
                        8.7.1. Bioanalytical Testing Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.8. Clinical Trial Data Management Services
                        8.8.1. Clinical Trial Data Management Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.9. Others
                        8.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. U.S. Clinical Trials Market: Sponsor Estimates & Trend Analysis
                    9.1. Segment Dashboard
                    9.2. Clinical Trials Market: Sponsor Movement Analysis & Market Share, 2024 & 2030
                    9.3. Pharmaceutical & Biopharmaceutical Companies
                        9.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.4. Medical Device Companies
                        9.4.1. Medical Device Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Market Participant Categorization
                        10.1.1. Market Leaders
                        10.1.2. Emerging Players
                    10.2. Market Position Analysis, 2024
                    10.3. Key Company Profiles
                        10.3.1. IQVIA
                            10.3.1.1. Company Overview
                            10.3.1.2. Financial Performance
                            10.3.1.3. Service Benchmarking
                            10.3.1.4. Strategic Initiatives
                        10.3.2. Fortrea Inc.
                            10.3.2.1. Company Overview
                            10.3.2.2. Financial Performance
                            10.3.2.3. Service Benchmarking
                            10.3.2.4. Strategic Initiatives
                        10.3.3. PAREXEL International Corporation
                            10.3.3.1. Company Overview
                            10.3.3.2. Financial Performance
                            10.3.3.3. Service Benchmarking
                            10.3.3.4. Strategic Initiatives
                        10.3.4. Thermo Fisher Scientific Inc.
                            10.3.4.1. Company Overview
                            10.3.4.2. Financial Performance
                            10.3.4.3. Service Benchmarking
                            10.3.4.4. Strategic Initiatives
                        10.3.5. Charles River Laboratories
                            10.3.5.1. Company Overview
                            10.3.5.2. Financial Performance
                            10.3.5.3. Service Benchmarking
                            10.3.5.4. Strategic Initiatives
                        10.3.6. ICON Plc
                            10.3.6.1. Company Overview
                            10.3.6.2. Financial Performance
                            10.3.6.3. Service Benchmarking
                            10.3.6.4. Strategic Initiatives
                        10.3.7. Wuxi AppTec Inc.
                            10.3.7.1. Company Overview
                            10.3.7.2. Financial Performance
                            10.3.7.3. Service Benchmarking
                            10.3.7.4. Strategic Initiatives
                        10.3.8. Medpace
                            10.3.8.1. Company Overview
                            10.3.8.2. Financial Performance
                            10.3.8.3. Service Benchmarking
                            10.3.8.4. Strategic Initiatives
                        10.3.9. Syneos Health
                            10.3.9.1. Company Overview
                            10.3.9.2. Financial Performance
                            10.3.9.3. Service Benchmarking
                            10.3.9.4. Strategic Initiatives
                        10.3.10. AstraZeneca
                            10.3.10.1. Company Overview
                            10.3.10.2. Financial Performance
                            10.3.10.3. Service Benchmarking
                            10.3.10.4. Strategic Initiatives
                        10.3.11. Merck & Co.
                            10.3.11.1. Company Overview
                            10.3.11.2. Financial Performance
                            10.3.11.3. Service Benchmarking
                            10.3.11.4. Strategic Initiatives
                        10.3.12. Eli Lilly and Company
                            10.3.12.1. Company Overview
                            10.3.12.2. Financial Performance
                            10.3.12.3. Service Benchmarking
                            10.3.12.4. Strategic Initiatives
                        10.3.13. Novo Nordisk A/S
                            10.3.13.1. Company Overview
                            10.3.13.2. Financial Performance
                            10.3.13.3. Service Benchmarking
                            10.3.13.4. Strategic Initiatives
                        10.3.14. Pfizer
                            10.3.14.1. Company Overview
                            10.3.14.2. Financial Performance
                            10.3.14.3. Service Benchmarking
                            10.3.14.4. Strategic Initiatives
                        10.3.15. Caidya
                            10.3.15.1. Company Overview
                            10.3.15.2. Financial Performance
                            10.3.15.3. Service Benchmarking
                            10.3.15.4. Strategic Initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 4. U.S. Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 5. U.S. Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 6. U.S. Clinical Trials Market, Indication by Study Design, 2018 - 2030 (USD Million)
Table 7. U.S. Clinical Trials Market, by Service, 2018 - 2030 (USD Million)
Table 8. U.S. Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
Table 9. Participant’s Overview
Table 10. Financial Performance
Table 11. Service Benchmarking
Table 12. Strategic Initiatives

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Clinical Trials Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 PESTEL by SWOT Analysis
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 U.S. Clinical Trials Market, for Phase I, 2018 - 2030 (USD Million)
Fig. 13 U.S. Clinical Trials Market, for Phase II, 2018 - 2030 (USD Million)
Fig. 14 U.S. Clinical Trials Market, for Phase III, 2018 - 2030 (USD Million)
Fig. 15 U.S. Clinical Trials Market, for Phase IV, 2018 - 2030 (USD Million)
Fig. 16 U.S. Clinical Trials Market, for Interventional, 2018 - 2030 (USD Million)
Fig. 17 U.S. Clinical Trials Market, for Observational, 2018 - 2030 (USD Million)
Fig. 18 U.S. Clinical Trials Market, for Expanded Access, 2018 - 2030 (USD Million)
Fig. 19 U.S. Clinical Trials Market, for Autoimmune/Inflammation, 2018 - 2030 (USD Million)
Fig. 20 U.S. Clinical Trials Market, for Rheumatoid Arthritis, 2018 - 2030 (USD Million)
Fig. 21 U.S. Clinical Trials Market, for Multiple Sclerosis, 2018 - 2030 (USD Million)
Fig. 22 U.S. Clinical Trials Market, for Osteoarthritis, 2018 - 2030 (USD Million)
Fig. 23 U.S. Clinical Trials Market, for Irritable Bowel Syndrome (IBS), 2018 - 2030 (USD Million)
Fig. 24 U.S. Clinical Trials Market, for Others, 2018 - 2030 (USD Million)
Fig. 25 U.S. Clinical Trials Market, for Pain Management, 2018 - 2030 (USD Million)
Fig. 26 U.S. Clinical Trials Market, for Chronic Pain, 2018 - 2030 (USD Million)
Fig. 27 U.S. Clinical Trials Market, for Acute Pain, 2018 - 2030 (USD Million)
Fig. 28 U.S. Clinical Trials Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 29 U.S. Clinical Trials Market, for Blood Cancer, 2018 - 2030 (USD Million)
Fig. 30 U.S. Clinical Trials Market, for Solid Tumors, 2018 - 2030 (USD Million)
Fig. 31 U.S. Clinical Trials Market, for Others, 2018 - 2030 (USD Million)
Fig. 32 U.S. Clinical Trials Market, for CNS Conditions, 2018 - 2030 (USD Million)
Fig. 33 U.S. Clinical Trials Market, for Epilepsy, 2018 - 2030 (USD Million)
Fig. 34 U.S. Clinical Trials Market, for Parkinson's Disease (PD), 2018 - 2030 (USD Million)
Fig. 35 U.S. Clinical Trials Market, for Huntington's Disease, 2018 - 2030 (USD Million)
Fig. 36 U.S. Clinical Trials Market, for Stroke, 2018 - 2030 (USD Million)
Fig. 37 U.S. Clinical Trials Market, for Traumatic Brain Injury (TBI), 2018 - 2030 (USD Million)
Fig. 38 U.S. Clinical Trials Market, for Amyotrophic Lateral Sclerosis (ALS), 2018 - 2030 (USD Million)
Fig. 39 U.S. Clinical Trials Market, for Muscle Regeneration, 2018 - 2030 (USD Million)
Fig. 40 U.S. Clinical Trials Market, for Others, 2018 - 2030 (USD Million)
Fig. 41 U.S. Clinical Trials Market, for Diabetes, 2018 - 2030 (USD Million)
Fig. 42 U.S. Clinical Trials Market, for Obesity, 2018 - 2030 (USD Million)
Fig. 43 U.S. Clinical Trials Market, for Cardiovascular, 2018 - 2030 (USD Million)
Fig. 44 U.S. Clinical Trials Market, for Others, 2018 - 2030 (USD Million)
Fig. 45 U.S. Clinical Trials Market, for Autoimmune/Inflammation Interventional, 2018 - 2030 (USD Million)
Fig. 46 U.S. Clinical Trials Market, for Autoimmune/Inflammation Observational, 2018 - 2030 (USD Million)
Fig. 47 U.S. Clinical Trials Market, for Autoimmune/Inflammation Expanded Access, 2018 - 2030 (USD Million)
Fig. 48 U.S. Clinical Trials Market, for Pain Management Interventional, 2018 - 2030 (USD Million)
Fig. 49 U.S. Clinical Trials Market, for Pain Management Observational, 2018 - 2030 (USD Million)
Fig. 50 U.S. Clinical Trials Market, for Pain Management Expanded Access, 2018 - 2030 (USD Million)
Fig. 51 U.S. Clinical Trials Market, for Oncology Interventional, 2018 - 2030 (USD Million)
Fig. 52 U.S. Clinical Trials Market, for Oncology Observational, 2018 - 2030 (USD Million)
Fig. 53 U.S. Clinical Trials Market, for Oncology Expanded Access, 2018 - 2030 (USD Million)
Fig. 54 U.S. Clinical Trials Market, for CNS Conditions Interventional, 2018 - 2030 (USD Million)
Fig. 55 U.S. Clinical Trials Market, for CNS Conditions Observational, 2018 - 2030 (USD Million)
Fig. 56 U.S. Clinical Trials Market, for CNS Conditions Expanded Access, 2018 - 2030 (USD Million)
Fig. 57 U.S. Clinical Trials Market, for Diabetes Interventional, 2018 - 2030 (USD Million)
Fig. 58 U.S. Clinical Trials Market, for Diabetes Observational, 2018 - 2030 (USD Million)
Fig. 59 U.S. Clinical Trials Market, for Diabetes Expanded Access, 2018 - 2030 (USD Million)
Fig. 60 U.S. Clinical Trials Market, for Obesity Interventional, 2018 - 2030 (USD Million)
Fig. 61 U.S. Clinical Trials Market, for Obesity Observational, 2018 - 2030 (USD Million)
Fig. 62 U.S. Clinical Trials Market, for Obesity Expanded Access, 2018 - 2030 (USD Million)
Fig. 63 U.S. Clinical Trials Market, for Cardiovascular Interventional, 2018 - 2030 (USD Million)
Fig. 64 U.S. Clinical Trials Market, for Cardiovascular Observational, 2018 - 2030 (USD Million)
Fig. 65 U.S. Clinical Trials Market, for Cardiovascular Expanded Access, 2018 - 2030 (USD Million)
Fig. 66 U.S. Clinical Trials Market, for Other Indications Interventional, 2018 - 2030 (USD Million)
Fig. 67 U.S. Clinical Trials Market, for Other Indications Observational, 2018 - 2030 (USD Million)
Fig. 68 U.S. Clinical Trials Market, for Other Indications Expanded Access, 2018 - 2030 (USD Million)
Fig. 69 U.S. Clinical Trials Market, for Protocol Designing, 2018 - 2030 (USD Million)
Fig. 70 U.S. Clinical Trials Market, for Site Identification, 2018 - 2030 (USD Million)
Fig. 71 U.S. Clinical Trials Market, for Patient Recruitment, 2018 - 2030 (USD Million)
Fig. 72 U.S. Clinical Trials Market, for Laboratory Services, 2018 - 2030 (USD Million)
Fig. 73 U.S. Clinical Trials Market, for Bioanalytical Testing Services, 2018 - 2030 (USD Million)
Fig. 74 U.S. Clinical Trials Market, for Clinical Trial Data Management Services, 2018 - 2030 (USD Million)
Fig. 75 U.S. Clinical Trials Market, for Others, 2018 - 2030 (USD Million)
Fig. 76 U.S. Clinical Trials Market, for Pharmaceutical & Biopharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 77 U.S. Clinical Trials Market, for Medical Device Companies, 2018 - 2030 (USD Million)
Fig. 78 U.S. Clinical Trials Market, for Others, 2018 - 2030 (USD Million)